BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cho SH, Shin JH, Jang H, Park S, Kim HJ, Kim SE, Kim SJ, Kim Y, Lee JS, Na DL, Lockhart SN, Rabinovici GD, Seong JK, Seo SW; Alzheimer’s Disease Neuroimaging Initiative. Amyloid involvement in subcortical regions predicts cognitive decline. Eur J Nucl Med Mol Imaging 2018;45:2368-76. [PMID: 29980831 DOI: 10.1007/s00259-018-4081-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Kim SJ, Ham H, Park YH, Choe YS, Kim YJ, Jang H, Na DL, Kim HJ, Moon SH, Seo SW. Development and clinical validation of CT-based regional modified Centiloid method for amyloid PET. Alzheimers Res Ther 2022;14:157. [PMID: 36266688 DOI: 10.1186/s13195-022-01099-0] [Reference Citation Analysis]
2 Vlegels N, Ossenkoppele R, van der Flier WM, Koek HL, Reijmer YD, Wisse LE, Biessels GJ, Whitwell J; the Alzheimer’s Disease Neuroimaging Initiative. Does Loss of Integrity of the Cingulum Bundle Link Amyloid-β Accumulation and Neurodegeneration in Alzheimer’s Disease? JAD 2022. [DOI: 10.3233/jad-220024] [Reference Citation Analysis]
3 Beach TG. A History of Senile Plaques: From Alzheimer to Amyloid Imaging. J Neuropathol Exp Neurol 2022;81:387-413. [PMID: 35595841 DOI: 10.1093/jnen/nlac030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Kim JP, Chun MY, Kim S, Jang H, Kim HJ, Jeong JH, Na DL, Seo SW. Distinctive Temporal Trajectories of Alzheimer’s Disease Biomarkers According to Sex and APOE Genotype: Importance of Striatal Amyloid. Front Aging Neurosci 2022;14:829202. [DOI: 10.3389/fnagi.2022.829202] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kim JS, Son HJ, Oh M, Lee DY, Kim HW, Oh J. 60 Years of Achievements by KSNM in Neuroimaging Research. Nucl Med Mol Imaging. [DOI: 10.1007/s13139-021-00727-1] [Reference Citation Analysis]
6 Levin F, Jelistratova I, Betthauser TJ, Okonkwo O, Johnson SC, Teipel SJ, Grothe MJ. In vivo staging of regional amyloid progression in healthy middle-aged to older people at risk of Alzheimer's disease. Alzheimers Res Ther 2021;13:178. [PMID: 34674764 DOI: 10.1186/s13195-021-00918-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Peira E, Grazzini M, Bauckneht M, Sensi F, Bosco P, Arnaldi D, Morbelli S, Chincarini A, Pardini M, Nobili F. Probing the Role of a Regional Quantitative Assessment of Amyloid PET. J Alzheimers Dis 2021;80:383-96. [PMID: 33554908 DOI: 10.3233/JAD-201156] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Kang SH, Kim J, Kim JP, Cho SH, Choe YS, Jang H, Kim HJ, Koh SB, Na DL, Seong JK, Seo SW. Harmonisation of PET imaging features with different amyloid ligands using machine learning-based classifier. Eur J Nucl Med Mol Imaging 2021. [PMID: 34328533 DOI: 10.1007/s00259-021-05499-6] [Reference Citation Analysis]
9 Cho SH, Choe YS, Kim YJ, Kim HJ, Jang H, Kim Y, Kim SE, Kim SJ, Kim JP, Jung YH, Kim BC, Lockhart SN, Farrar G, Na DL, Moon SH, Seo SW. Head-to-Head Comparison of 18F-Florbetaben and 18F-Flutemetamol in the Cortical and Striatal Regions. J Alzheimers Dis 2020;76:281-90. [PMID: 32474468 DOI: 10.3233/JAD-200079] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
10 Buckley RF. Recent Advances in Imaging of Preclinical, Sporadic, and Autosomal Dominant Alzheimer's Disease. Neurotherapeutics 2021. [PMID: 33782864 DOI: 10.1007/s13311-021-01026-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
11 Kang SK, Choi H, Lee JS; Alzheimer's Disease Neuroimaging Initiative. Translating amyloid PET of different radiotracers by a deep generative model for interchangeability. Neuroimage 2021;232:117890. [PMID: 33617991 DOI: 10.1016/j.neuroimage.2021.117890] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
12 Kim SE, Lee B, Jang H, Chin J, Khoo CS, Choe YS, Kim JS, Kang SH, Kim HR, Hwangbo S, Jeong JH, Yoon SJ, Park KW, Kim EJ, Yoon B, Jang JW, Hong JY, Na DL, Seo SW, Choi SH, Kim HJ. Cognitive trajectories of patients with focal ß-amyloid deposition. Alzheimers Res Ther 2021;13:48. [PMID: 33608041 DOI: 10.1186/s13195-021-00787-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Teipel SJ, Temp AGM, Levin F, Dyrba M, Grothe MJ; Alzheimer's Disease Neuroimaging Initiative. Association of PET-based stages of amyloid deposition with neuropathological markers of Aβ pathology. Ann Clin Transl Neurol 2021;8:29-42. [PMID: 33137247 DOI: 10.1002/acn3.51238] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
14 Jun S, Kim H, Kim BS, Yoo BG, Lee WG; Alzheimer’s Disease Neuroimaging Initiative. Quantitative Brain Amyloid Measures Predict Time-to-Progression from Amnestic Mild Cognitive Impairment to Alzheimer's Disease. J Alzheimers Dis 2019;70:477-86. [PMID: 31256127 DOI: 10.3233/JAD-190070] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Teipel SJ, Dyrba M, Chiesa PA, Sakr F, Jelistratova I, Lista S, Vergallo A, Lemercier P, Cavedo E, Habert MO, Dubois B, Hampel H, Grothe MJ. In vivo staging of regional amyloid deposition predicts functional conversion in the preclinical and prodromal phases of Alzheimer's disease. Neurobiology of Aging 2020;93:98-108. [DOI: 10.1016/j.neurobiolaging.2020.03.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
16 Gonneaud J, Bedetti C, Pichet Binette A, Benzinger TLS, Morris JC, Bateman RJ, Poirier J, Breitner JCS, Villeneuve S; DIAN Study Group and the PREVENT-AD Research Group. Association of education with Aβ burden in preclinical familial and sporadic Alzheimer disease. Neurology 2020;95:e1554-64. [PMID: 32759192 DOI: 10.1212/WNL.0000000000010314] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
17 Jelistratova I, Teipel SJ, Grothe MJ. Longitudinal validity of PET-based staging of regional amyloid deposition. Hum Brain Mapp 2020;41:4219-31. [PMID: 32648624 DOI: 10.1002/hbm.25121] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
18 Rullmann M, McLeod A, Grothe MJ, Sabri O, Barthel H; Alzheimer’s Disease Neuroimaging Initiative. Reshaping the Amyloid Buildup Curve in Alzheimer Disease? Partial-Volume Effect Correction of Longitudinal Amyloid PET Data. J Nucl Med 2020;61:1820-4. [PMID: 32358089 DOI: 10.2967/jnumed.119.238477] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
19 Yoo HS, Lee S, Chung SJ, Lee YH, Ye BS, Sohn YH, Yun M, Lee PH. Clinical and striatal dopamine transporter predictors of β-amyloid in dementia with Lewy bodies. Neurology 2020;94:e1344-52. [PMID: 32086384 DOI: 10.1212/WNL.0000000000009168] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
20 Kim SE, Lee B, Park S, Cho SH, Kim SJ, Kim Y, Jang H, Jeong JH, Yoon SJ, Park KW, Kim EJ, Jung NY, Yoon B, Jang JW, Hong JY, Hwang J, Na DL, Seo SW, Choi SH, Kim HJ. Clinical significance of focal ß-amyloid deposition measured by 18F-flutemetamol PET. Alzheimers Res Ther 2020;12:6. [PMID: 31901233 DOI: 10.1186/s13195-019-0577-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
21 Kim JP, Kim J, Kim Y, Moon SH, Park YH, Yoo S, Jang H, Kim HJ, Na DL, Seo SW, Seong JK. Staging and quantification of florbetaben PET images using machine learning: impact of predicted regional cortical tracer uptake and amyloid stage on clinical outcomes. Eur J Nucl Med Mol Imaging 2020;47:1971-83. [PMID: 31884562 DOI: 10.1007/s00259-019-04663-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
22 Sarbu M, Dehelean L, Munteanu CVA, Ica R, Petrescu AJ, Zamfir AD. Human caudate nucleus exhibits a highly complex ganglioside pattern as revealed by high-resolution multistage Orbitrap MS. Journal of Carbohydrate Chemistry 2019;38:531-51. [DOI: 10.1080/07328303.2019.1669632] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
23 Rahayel S, Bocti C, Sévigny Dupont P, Joannette M, Lavallée MM, Nikelski J, Chertkow H, Joubert S. Subcortical amyloid relates to cortical morphology in cognitively normal individuals. Eur J Nucl Med Mol Imaging 2019;46:2358-69. [DOI: 10.1007/s00259-019-04446-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
24 Rahayel S, Bocti C, Sévigny Dupont P, Joannette M, Lavallée MM, Nikelski J, Chertkow H, Joubert S. Subcortical amyloid load is associated with shape and volume in cognitively normal individuals. Hum Brain Mapp 2019;40:3951-65. [PMID: 31148327 DOI: 10.1002/hbm.24680] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
25 Chincarini A, Peira E, Morbelli S, Pardini M, Bauckneht M, Arbizu J, Castelo-Branco M, Büsing KA, de Mendonça A, Didic M, Dottorini M, Engelborghs S, Ferrarese C, Frisoni GB, Garibotto V, Guedj E, Hausner L, Hugon J, Verhaeghe J, Mecocci P, Musarra M, Queneau M, Riverol M, Santana I, Guerra UP, Nobili F. Semi-quantification and grading of amyloid PET: A project of the European Alzheimer's Disease Consortium (EADC). Neuroimage Clin 2019;23:101846. [PMID: 31077984 DOI: 10.1016/j.nicl.2019.101846] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
26 Thal DR, Beach TG, Zanette M, Lilja J, Heurling K, Chakrabarty A, Ismail A, Farrar G, Buckley C, Smith APL. Estimation of amyloid distribution by [18F]flutemetamol PET predicts the neuropathological phase of amyloid β-protein deposition. Acta Neuropathol 2018;136:557-67. [PMID: 30123935 DOI: 10.1007/s00401-018-1897-9] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 7.5] [Reference Citation Analysis]